That clinical trials for a cholesterol-lowering drug exceed expectations will boost the developer's stock, says CNBC's Jim Cramer.» Read More
NEW YORK, Aug 13- Biotechnology company InterMune Inc is working with financial advisers to evaluate strategic options as it braces for potential takeover interest from larger drugmakers, people familiar with the matter said.
NEW YORK, Aug 11- U.S. stocks rose broadly on Monday, extending Friday's sharp rally as recent uncertainty pertaining to Ukraine and the Middle East appeared to ease, while Priceline rallied on its results.
NEW YORK- Global stocks bounce after recent sell-offs and core government debt prices fall as markets see receding risks of direct conflict between Russia and Ukraine while Middle East tensions diminish.
*MannKind signs agreement with Sanofi, shares jump. NEW YORK, Aug 11- U.S. stocks rose on Monday, extending Friday's sharp rally as concerns eased over both Federal Reserve monetary policy and the tense situation between Russia and Ukraine.
*MannKind signs agreement with Sanofi, shares jump. NEW YORK, Aug 11- U.S. stock index futures pointed to a higher open on Monday, suggesting that Friday's sharp rally could continue as it appeared less likely that the tense situation between Russia and Ukraine would escalate.
*MannKind signs agreement with Sanofi, shares jump. NEW YORK, Aug 11- U.S. stock index futures were higher on Monday, indicating that Friday's sharp rally could continue as it appeared less likely that the tense situation between Russia and Ukraine would escalate.
*Sanofi, MannKind aim to launch Afrezza in U.S. in Q1 2015. PARIS/ LONDON, Aug 11- French drugmaker Sanofi is betting on inhaled insulin as an alternative option to daily injections for diabetics by signing a worldwide licensing agreement with MannKind Corp worth up to $925 million.
NEW YORK, Aug 5- Belgian pharmaceutical company UCB is exploring a sale of its Kremers Urban Pharmaceuticals Inc division, a U.S. specialty generics business that could fetch as much as $2 billion, according to people familiar with the matter. Other companies that are exploring similar sales include GlaxoSmithKline Plc, Sanofi SA and Merck& Co Inc..
Aug 5- Regeneron Pharmaceuticals Inc on Tuesday reported higher-than-expected quarterly revenue and earnings on surging demand for its Eylea treatment for macular degeneration, and stuck to its full-year sales forecast for the drug.
*Shares in Adidas and Banco Espirito Santo slump. LONDON, July 31- European shares fell sharply on Thursday, with the euro zone's blue-chip index slipping to a three-month low, on concerns of an earlier than expected interest rate hike in the Uniteed States and a debt default by Argentina.
European shares closed lower on Thursday with investors reacting to quarterly earnings and some disappointing data from the euro zone.
Some of the names on the move ahead of the open.
*Adidas, Banco Espirito Santo shares slump. LONDON/ PARIS, July 31- Europe's FTSEurofirst 300 index of top shares slipped to a two-week low on Thursday, led lower by Adidas after the group warned about business in Russia, while Argentina's default also rattled investors.
PARIS, July 31- European shares fell in early trade on Thursday, led by Adidas after the group warned about business in Russia, while Argentina's default also rattled investors. Spanish stocks also underperformed, with Madrid's IBEX dropping 1.5 percent, as traders cited worries over Spanish companies' exposure to Latin America after Argentina's debt default.
PARIS, July 31- European shares were steady in early trade on Thursday as investors combed through a batch of corporate results from blue-chips such as Sanofi, Anheuser-Busch InBev and Royal Dutch Shell.
PARIS, July 31- French drugmaker Sanofi raised its full-year profit forecast on Thursday along with a set of stronger than expected quarterly earnings driven by its rare disease and diabetes businesses and higher sales in emerging markets.
Some of Wednesday's midday movers:
*Sanofi to file drug for US and EU approval by year-end. PARIS, July 30- A new drug being developed by French drugmaker Sanofi and U.S. partner Regeneron cut "bad" LDL cholesterol more than placebo and existing treatments in nine late-stage clinical trials, the companies said on Wednesday.
BEIJING, July 28- Microsoft Corp appears to be the latest U.S. company targeted by China for anti-trust investigation after government officials paid sudden visits to the software firm's Chinese offices on Monday.
A crush of big cap earnings and arguably the most important economic reports until September make next week the busiest of the summer for markets.